Emerging infectious diseases: Concepts in preparing for and responding to the next microbial threat

Koenig and schultz's Disaster Medicine: Comprehensive Principles and Practices

Volumn , Issue , 2009, Pages 75-102

  Gamage, Shantini D ^a   Kralovic, Stephen M ^a,b   Roselle, Gary A ^a,b  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84924550925     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511902482.008     Document Type: Chapter

References (57)

1. Taylor LH, Latham SM, Woolhouse ME. Risk factors for human disease emergence. Phil Trans R Soc Lond B Biol Sci. 2001;356(1411):983–989.
2. Lashley FR. Factors contributing to the occurrence of emerging infectious diseases. Biol Res Nurs. 2004;4(4):258-267.
3. Institute of Medicine. Microbial Threats to Health: Emergence, Detection and Response. Washington, DC: National Academies Press; 2003.
4. Institute of Medicine. Biological Threats and Terrorism: Assessing the Science and Response Capabilities. Washington, DC: National Academies Press; 2002.
5. Naylor CD, Chantler C, Griffiths S. Learning from SARS in Hong Kong and Toronto. JAMA. 2004;291(20):2483-2487.
6. Enserink M. SARS in China. China’s missed dance. Science. 2003;301(5631):294-296.
7. U.S. Centers for Disease Control and Prevention. Update: severe acute respiratory syndrome - Toronto, Canada. MMWR. 2003;52(23):547-550.
8. Osterholm MT. How to vaccinate 30,000 people in three days: realities of outbreak management. Pub Health Report. 2001;116 (Suppl. 2):74–78.
9. Ferguson NM, Cummings DAT, Fraser C, Cajka, JC, Cooley PC, Burke DS. Strategies for mitigating an influenza pandemic. Nature. 2006;442(7101):448–452.
10. U.S. Centers for Disease Control and Prevention. Severe acute respiratory syndrome - Singapore, 2003. MMWR. 2003;52(18): 405-411.
11. Berg, R. Salmonella Saint Paul: what went wrong? J Environ Health. 2008; 71(5):50-52.
12. McDonald LC, Simor AE, Su I-J, et al. SARS in healthcare facilities, Toronto and Taiwan. EmergInfect Dis. 2004;10(5):777-781.
13. Peters CJ, LeDuc JW. An introduction to Ebola: the virus and the disease. J Infect Dis. 1999;179(Suppl 1):ix–xvi.
14. Qureshi K, Gershon RRM, Sherman MF, etal. Health care workers’ ability and willingness to report to duty during catastrophic disasters. J Urban Health Bull NY Acad Med. 2005;82(3):378- 388.
15. Shepard CW, Soriano-Gabarro M, Zell ER, et al. Antimicrobial postexposure for anthrax: adverse events and adherence. Emerg Infect Dis. 2002;8(10):1124-1132.
16. Hawryluck L, Gold WL, Robinson S, Pogorski S, Galea S, Styra R. SARS control and psychological effects of quarantine, Toronto, Canada. Emerg Infect Dis. 2004;10(7):1206-1212.
17. O’Toole T, Mair M, Inglesby TV. Shining light on “Dark Winter.” Clin Infect Dis. 2002;34(7):972-983.
18. Wynia MK, Gostin LO. Ethical challenges in preparing for bioterrorism: barriers within the healthcare system. Am J Pub Health. 2004;94(7):1096-1102.
19. Beecher DJ. Forensic application of microbiological culture analysis to identify mail intentionally contaminated with Bacillus anthracis spores. Appl Environ Microbiol. 2006;72(8):5304- 5310.
20. Homeland Security. National Response Plan. December 2004. Available at: http://www.dhs.gov/xprepresp/committees/editorial_0566.shtm. Accessed November 12, 2008.
21. U.S. House of Representatives. February 15, 2006. A failure of initiatives. Final report of the Select Bipartisan Committee to investigate the preparation for and response to hurricane Katrina. 109th Congress, 2nd Session. Available at: http://katrina.house.gov/full_katrina_report.htm. Accessed November 12, 2008.
22. Federal Emergency Management Agency. September 12, 2006. NIMS Alert. NIMS implementation activities for hospitals and healthcare systems. Available at: http://www.fema.gov/pdf/emergency/nims/imp_act_hos_hlth.pdf. Accessed November 12, 2008.
23. Arnold JL, Dembry L-M, Tsai M-C, et al. Recommended modifications and applications of the hospital emergency incident command system for hospital emergency management. Preshosp Disaster Med. 2005;20(5):290-300.
24. Rubinson L, Nuzzo JB, Talmor DS, O’Toole T, Kramer BR, Inglesby TV, for the Working Group on Emergency Mass Critical Care. Augmentation of hospital critical care capacity after bioterrorist attacks or epidemics: recommendations of the Working Group on Emergency Mass Critical Care. Crit Care Med. 2005;33(10):2393-2403.
25. Fumento MJ. The threat of an avian flu pandemic is over-hyped. Virtual Mentor. 2006;8(4):265-270.
26. U.S. General Accounting Office. West Nile virus outbreak. Lessons for public health preparedness. GAO/HEHS-00-180. Washington, DC: General Accounting Office; 2000.
27. Chan PKS. Outbreak of avian influenza (H5N1) virus infection in Hong Kong in 1997. Clin Infect Dis. 2002;34(Suppl2):S58-64.
28. Chua KB. Nipah virus outbreak in Malaysia. J Clin Virol. 2003;26(3):265-275.
29. Ksiazek TG, Erdman D, Goldsmith CS, et al. A novel coronavirus associated with severe acute respiratory syndrome. NEngl JMed. 2003;348(20):1953-1966.
30. Spellberg B, Powers JH, Brass EP, Miller LG, Edwards JE Trends in antimicrobial drug development: implications for the future. Clin Infect Dis. 2004;38(9):1279-1286.
31. Stockman LJ, Bellamy R, Garner P. SARS: systematic review of treatment effects. PLoS Med. 2006;3(9):e343.
32. American Society for Microbiology. ASM comments on the Biodefense and Pandemic Vaccine and Drug Development Act of 2005. November 4, 2005. Available at: www.asm.org/Policy/index.asp?bid=38723. Accessed November 12, 2008.
33. Institute of Medicine. Learning from SARS: Preparing for the Next Disease Outbreak. Washington, DC: National Academies Press; 2004.
34. Svoboda T, Henry B, Shulman L, et al. Public health measures to control the spread of the severe acute respiratory syndrome during the outbreak in Toronto. N Engl J Med. 2004;350(23):2351– 2361.
35. U.S. General Accounting Office. Influenza pandemic. Challenges in preparedness and response. GAO-05-863T. Washington, DC: General Accounting Office; 2005.
36. Bardi J. Aftermath of a hypothetical smallpox disaster. Emerg Infect Dis. 1999;5(4):547-551.
37. Hick JL, O’Laughlin DT. Concept of operations for triage of mechanical ventilation in an epidemic. Acad Emerg Med. 2006;13(2):223-229.
38. Burkle FM. Population-based triage management in response to surge-capacity requirements during a large-scale bioevent disaster. Acad Emerg Med. 2006;13(11):1118–1129.
39. Osterholm MT. Preparing for the next pandemic. N Engl J Med. 2005;352(18):1839–1842.
40. American College of Emergency Physicians. National Strategic Plan for Emergency Department Management of Outbreaks of Novel H1N1 Influenza. Available at: http://acep.org/WorkArea/DownloadAsset.aspx?id=45781 Accessed on July 12, 2009.
41. DHS Office of Inspector General. November 2005. A review of the Top Officials 3 exercise. https://www.dhs.gov/xoig/assets/mgmtrpts/OIG_06-07_Nov05.pdf. Accessed December 5, 2006.
42. Lobitz B, Beck L, Huq A, et al. Climate and infectious disease: use of remote sensing for detection of Vibrio cholerae by indirect measurement. Proc Natl Acad Sci USA. 2000;97(4):1438– 1443.
43. Ferguson NM, Cummings DA, Cauchemez S, et al. Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature. 2005;437(7056):209–214.
44. Gani R, Hughes H, Fleming D, Griffin T, Medlock J, Leach S. Potential impact of antiviral drug use during influenza pandemic. Emerg Infect Dis. 2005;11(9):1355–1362.
45. Longini IM, Nizam A, Xu S, et al. Containing pandemic influenza at the source. Science. 2005;309(5737):1083– 1087.
46. Meltzer MI, Damon I, LeDuc JW, Millar JD. Modeling potential responses to smallpox as a bioterrorist weapon. Emerg Infeđ Dis. 2001;7(6):959–969.
47. Asch SM, Stoto, M, Mendes M, et al. A review of instruments assessing public health preparedness. Pub Health Report. 2005;120(5):532–542.
48. Amadio JB. Bioterrorism preparedness funds well used at the local level. Am J Pub Health. 2004;95(3):373-374.
49. Cohen H.W, Gould RM, Sidel VW. The pitfalls of bioterrorism preparedness: the anthrax and smallpox experiences. Am J Pub Health. 2004;94(10):1667-1671.
50. Wortley PM, Schwartz B, Levy PS, Quick LM, Evans B, Burke, B. Healthcare workers who elected not to receive smallpox vaccination. Am J Prevent Med. 2006. 30(3):258-265.
51. Institute of Medicine. Ending the War Metaphor: The Changing Agenda for Unraveling the Host-Microbe Relationship. Washington, DC: National Academies Press; 2006.
52. King DA, Peckham C, Waage JK, Brownlie J, Woolhouse ME. Epidemiology. Infectious diseases: preparing for the future. Science. 2006;313(5792):1392-1393.
53. Pulendran B, Ahmed R. Translating innate immunity into immunological memory: implications for vaccine development. Cell. 2006;124(4):849-863.
54. Liu MA, Wahren B, Karlsson Hedestam GB. DNA vaccines: recent developments and future possibilities. Hum Gene Ther. 2006;17(11):1051-1061.
55. Daszak P, Tabor GM, Kilpatrick AM, Epstein J, Plowright R. Conservation medicine and a new agenda for emerging diseases. Ann NY Acad Sci. 2004;1026:1-11.
56. Rogers DJ, Randolph SE. Studying the global distribution of infectious diseases using GIS and RS. Nat Rev Microbiol. 2003;1(3):231-237.
57. Scholthof KBG. The disease triangle: pathogens, the environment and society. Nat Rev Microbiol. 2007;5(2):152-156.